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Cigarette smoking causes chronic lung inflammation that is mainly regulated by
redox-sensitive pathways. Our previous studies have demonstrated that cigarette smoke
(CS) activates reactive oxygen species (ROS)-sensitive mitogen-activated protein kinases
(MAPKs)/nuclear factor-κB (NF-κB) signaling resulting in induction of lung inflammation.
Eicosapentaenoic acid (EPA), a major type of omega-3 polyunsaturated fatty acid, is
present in significant amounts in marine-based fish and fish oil. EPA has been shown
to possess antioxidant and anti-inflammatory properties in vitro and in vivo. However,
whether EPA has similar beneficial effects against CS-induced lung inflammation remains
unclear. Using a murine model, we show that subchronic CS exposure for 4 weeks
caused pulmonary inflammatory infiltration (total cell count in bronchoalveolar lavage
fluid (BALF), 11.0-fold increase), increased lung vascular permeability (protein level in
BALF, 3.1-fold increase), elevated levels of chemokines (11.4–38.2-fold increase) and
malondialdehyde (an oxidative stress biomarker; 2.0-fold increase) in the lungs, as
well as lung inflammation; all of these CS-induced events were suppressed by daily
supplementation with EPA. Using human bronchial epithelial cells, we further show that
CS extract (CSE) sequentially activated NADPH oxidase (NADPH oxidase activity, 1.9-fold
increase), increased intracellular levels of ROS (3.0-fold increase), activated both MAPKs
and NF-κB, and induced interleukin-8 (IL-8; 8.2-fold increase); all these CSE-induced events
were inhibited by pretreatment with EPA. Our findings suggest a novel role for EPA in
alleviating the oxidative stress and lung inflammation induced by subchronic CS exposure
in vivo and in suppressing the CSE-induced IL-8 in vitro via its antioxidant function and by
inhibiting MAPKs/NF-κB signaling.
Keywords: eicosapentaenoic acid, cigarette smoke, lung inflammation, reactive oxygen species, signal
transduction, chemokines, lung epithelial cells
INTRODUCTION
Cigarette smoking is the major etiologic factor in the develop-
ment of chronic obstructive pulmonary disease (COPD), which is
characterized by chronic lung inflammation (Chung and Adcock,
2008). Cigarette smoke (CS)-induced lung inflammation is regu-
lated by a complex mechanism that involves various types of cells
and a number of inflammatory mediators (Barnes, 2004; Chung
and Adcock, 2008). For example, because the lung epithelium is
a target for direct insult by CS, chemokines such as interleukin-
8 (IL-8), which are released from lung epithelial cells, play an
important role in the initiation and progression of lung inflam-
mation (Mio et al., 1997; Mossman et al., 2006; Thorley and
Tetley, 2007; Moretto et al., 2008; Tang et al., 2011; Liu et al.,
2014; Wu et al., 2014). The induction of inflammatory mediators
by CS in various types of lung cells is mainly regulated by redox-
sensitive signaling pathways (Mossman et al., 2006; Rahman and
Adcock, 2006). Initially, CS may increase the intracellular levels
of reactive oxygen species (ROS) in lung cells, mainly via acti-
vation of NADPH oxidase (Mossman et al., 2006; Rahman and
Adcock, 2006; Cheng et al., 2009; Lin et al., 2010; Tang et al., 2011;
Liu et al., 2014; Wu et al., 2014). Subsequently, this increased
in intracellular ROS may serve as the trigger to activate various
ROS-sensitive signaling pathways, such as the mitogen-activated
protein kinases (MAPKs) and a number of downstream transcrip-
tional factors, such as nuclear factor-κB (NF-κB); this ultimately
increase the production of inflammatory mediators (Mossman
et al., 2006; Rahman and Adcock, 2006; Tang et al., 2011; Liu
et al., 2014; Wu et al., 2014). Due to the involvement of the
ROS-sensitive signaling pathways, dietary antioxidant therapies
targeting oxidative stress should be beneficial and help to improve
CS-induced lung inflammation (Biswas et al., 2013).
Omega-3 polyunsaturated fatty acids (n-3 PUFAs) are present
in significant amounts in marine-based fish and fish oil and have
long been known to possess a wide range of beneficial effects,
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including the treatment of various forms of chronic inflamma-
tory diseases (Chapkin et al., 2009; Giudetti and Cagnazzo, 2012;
Davidson, 2013). Recently, there has been a growing interest in
the beneficial effect of eicosapentaenoic acid (EPA), a major type
of n-3 PUFAs (Davidson, 2013). For example, a clinical trial has
revealed that highly purified EPA prevents the onset of cardiovas-
cular events in hypercholesterolaemic patients (Yokoyama et al.,
2007). Additionally, EPA has been shown to suppress inflamma-
tory responses to stimuli other than CS in a number of animal
models (Okabe et al., 2011; Jia et al., 2012; Poudyal et al., 2013;
Schuster et al., 2014) and in various cell types (Moon et al.,
2007; Mickleborough et al., 2009; Mullen et al., 2010; Wang et al.,
2010; Jinno et al., 2011; Jung et al., 2012; Magee et al., 2012;
van den Elsen et al., 2013). Furthermore, EPA has been reported
to possess antioxidant activity when prescribed to treat patients
(Mahmoudabadi and Rahbar, 2014) or when used as in vitro
(Richard et al., 2008; Kusunoki et al., 2013; van den Elsen et al.,
2013) or in vivo preparations (Okabe et al., 2011; Palaniswamy
et al., 2014). Thus, the antioxidant and anti-inflammatory prop-
erties of EPA make it a potential drug for the treatment of
CS-induced lung inflammation. However, this possibility remains
to be proven.
The aims of this study were, firstly, to investigate the antiox-
idant and anti-inflammatory effects of EPA on CS-induced lung
inflammation and, secondly, to determine any therapeutic mech-
anisms underlying the beneficial effects of EPA. We used an
established murine model of subchronic CS exposure (Tang et al.,
2011; Wu et al., 2014) to assess the inhibitory effects of EPA
on oxidative stress and various indices of lung inflammation.
Additionally, we used primary human bronchial epithelial cells
(HBECs) to determine the suppressive effects of EPA on the CS
extract (CSE)-mediated increases in intracellular ROS, activation




Antibodies (Abs) and ELISA kits to measure IL-8, macrophage
inflammatory protein 2 (MIP-2), monocyte chemoattrac-
tant protein-1 (MCP-1) and keratinocyte chemoattractant
(KC) were purchased from R&D Systems (Minneapolis, MN,
USA). Malondialdehyde (MDA) was purchased from Abcam
(Cambridge, MA, USA). Antibodies against ERK, JNK, phospho-
ERK, phospho-JNK, p65, and Histone H1 were obtained from
Santa Cruz Biotechnology (Santa Cruz, CA, USA). Mouse anti-
body against α-tubulin, EPA (purity ≥99%) and the 3-(4,5-
dimethylthiazol-2-yl)-2,5 diphenyltetrazolium bromide (MTT)
assay kit were purchased from Sigma-Aldrich (St. Louis, MO,
USA). The EnzyChrom NADP+/NADPH assay kit was obtained
from BioAssay Systems (Hayward, CA, USA). The membrane-
permeable probes hydroethidine (HE) and dichlorofluorescein
diacetate (DCFH-DA) were purchased from Molecular Probes
(Eugene, OR, USA).
MURINE MODEL OF SUBCHRONIC CS EXPOSURE AND EPA
TREATMENT
All animal experiments were approved by the Animal Care
and Use Committee of the National Yang-Ming University. The
murine model of subchronic CS exposure has been described
in detail previously (Tang et al., 2011; Wu et al., 2014). Briefly,
male C57BL/6J mice at the age of 8 weeks (National Laboratory
Animal Center, Taipei, Taiwan) were randomly divided into four
groups (7 mice/group) for exposure to air or CS. These mice
received daily treatment with EPA (50mg/kg) or saline (vehi-
cle control) by gastric gavage during the 4-week exposure. The
mice formed four groups, namely Air, Air+EPA, CS, and CS+EPA.
Animals were given ad libitum access to food and water, and
their average body weights did not vary among the study groups
at the end of the 4-week exposure. For each CS exposure, the
mice were placed in an exposure chamber (40 × 30× 20 cm; Shin
Chen EEC-1, Taipei, Taiwan) and 750ml of fresh CS generated
from 1.5 cigarettes (Marlboro Red Label; 10.8mg nicotine and
10.0mg tar per cigarette) was delivered to the chamber. The
CS passed out of the chamber via four exhaust holes (1 cm)
on the side panels. During the exposure, the mice were con-
scious and breathed spontaneously in the chamber for 10min.
After exposure, the mice were transferred to a new cage and
allowed to inspire air normally. The mice were exposed at 10:00
and 16:00 each day for 4 weeks. The control animals under-
went identical procedures in another chamber but were only
exposed to air. For each CS exposure, the particle concentra-
tion inside the exposure chamber was about 625mg/m3 ini-
tially, but decreased overtime due to the fact that the CS passed
out of the chamber via the exhaust holes (Wu et al., 2014).
The HbCO levels immediately after the 10min exposure proto-
col for air-exposure and CS-exposure mice were 0.4 and 32%,
respectively (Wu et al., 2014).
PREPARATION OF BRONCHOALVEOLAR (BALF) AND LUNG TISSUES
At the end of each experiment, the mice were euthanized with
CO2 and a middle thoracotomy was performed. The left lung
was ligated and the right lung was lavaged four times with 0.4ml
of warm PBS containing a complete protease inhibitor cocktail
(Roche Diagnostics, Mannheim, Germany). The BALF samples
were then centrifuged at 350 × g for 5min at 4◦C, and the
supernatant of the first lavage fluid was stored at −80◦C for
later analysis of total protein using Bio-Rad protein assay reagent
(Bio-Rad Laboratories, Hercules, CA, USA). The cell pellets of
the BALF samples were re-suspended in PBS for cell counting.
Furthermore, the right lung was then stored at −80◦C for subse-
quent analysis. The left lung was fixed with 4% paraformaldehyde
and embedded in paraffin.
HISTOLOGICAL ASSESSMENT
Formalin-fixed, paraffin-embedded tissue blocks were cut into
8-μm sections. Sections were deparaffinized, rehydrated, and
then underwent haematoxylin and eosin (H&E) staining and
were viewed under a microscope (Motic TYPE 102M, Xiamen,
China). The histological assessments were conducted by a
pathologist who was blinded to the treatment. Each histo-
logical characteristic was scored on a scale of 0 (normal) to
5 (maximal). The lung inflammatory scores were categorized
according to the sum of the score for infiltration cell num-
bers and for damage levels, including thickening of alveo-
lar walls and epithelium, as well as increases in peribronchial
and perivascular cuff area.
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DETERMINING LUNG LEVELS OF CHEMOKINES AND OXIDATIVE
STRESS
The concentrations of MIP-2, MCP-1, and KC in the lung tissue
samples were measured using ELISA kits according to the man-
ufacturer’s instructions. In addition, levels of MDA, a product of
lipid peroxidation, in the lung tissue samples were measured by
assay kits according to the manufacturer’s instructions and the
results served as a biomarker for oxidative stress (Ardite et al.,
2006).
PREPARATION OF CSE
CSE was freshly prepared on the day of the experiment as pre-
viously described (Tang et al., 2011; Wu et al., 2014). In brief,
1000ml of the smoke generated from two burning cigarettes
(Marlboro Red Label) without filters were sucked at a constant
flow rate (8ml/s) into a syringe and then bubbled into a tube
containing 10ml serum-free medium. The CSE solution was ster-
ilized using a 0.22-μm filter (Millipore, Bedford, MA, USA) and
the pH was adjusted to 7.4. The optical density of the CSE solu-
tion was determined by measuring the absorbance at 302 nm
(Yamaguchi et al., 2007) or 320 nm (Facchinetti et al., 2007),
which, in reality, were found to show little difference between dif-
ferent preparations. This CSE solution was considered 100% CSE
and was further diluted with serum-free medium to the desired
concentrations, which were then used to treat HBECs for different
times.
CELL CULTURE
HBECs (Cascade Biologics, Portland, OR, USA) were cultured in
epithelial cell growth medium (F12Kmedium; Cascade Biologics,
USA) containing 10% fetal bovine serum (FBS), 100U/ml peni-
cillin, 100μg/ml streptomycin, and 0.25μg/ml amphotericin B
(Biological Industries, Kibbutz Beit Haemek, Israel) at 37◦C in an
incubator with 5% CO2.
CELL VIABILITY ASSAY
Cell viability was measured by the MTT assay as described pre-
viously (Liu et al., 2005). Briefly, cells were incubated with or
without EPA for 24 h and 100μl of MTT (0.5mg/ml in medium)
were then added. The cells incubated with control medium were
considered 100% viable.
MEASUREMENT OF INTRACELLULAR ROS LEVELS
The membrane-permeable probes HE and DCFH-DA were used
to assess levels of ROS using methods that have been described
previously (Liu et al., 2005). Oxidation of HE by ROS, preferen-
tially superoxide, forms red fluorescent ethidium (ETH) (Benov
et al., 1998), whereas oxidation of DCFH-DA by ROS, particularly
hydrogen peroxide, yields fluorescent 2,7-dichlorofluorescein
(DCF) (Myhre et al., 2003). For the purpose of these experiments,
HBECs were incubated in culture medium containing 10μMHE
or 20μM DCFH-DA at 37◦C for 30min. Then, cell medium
was replaced with fresh medium. After stimulation with CSE
for 30min, cells were washed and detached with trypsin/EDTA,
and the fluorescence intensity of the cells was analyzed by use
of a multilabel counter (PerkinElmer, Waltham, MA) at 518 nm
excitation and 605 nm emission for ETH, and at 488 nm excita-
tion and 530 nm emission for DCF. Images of the cells were also
obtained by examining them using a Nikon TE2000-U florescence
microscope (Tokyo, Japan).
DETERMINATION OF NADPH OXIDASE ACTIVITY
The activity of NADPH oxidase was measured using an
EnzyChrom™ NADP+/NADPH assay kit according to the man-
ufacturer’s instructions. This assay kit measures the change in
NADP+/NADPH ratio in cellular lysate samples and reflects the
relative NADPH oxidase activity of the samples tested.
WESTERN BLOT ANALYSIS
Aliquots of cell lysates or tissue lysates were separated by 8–12%
SDS-PAGE and then transblotted onto Immobilon™-P mem-
brane (Millipore). After being blocked with 5% skim milk,
the blots were incubated with various primary antibodies, and
then appropriate secondary antibodies. The specific protein
bands were detected using an enhanced chemiluminescence kit
(PerkinElmer), which was followed by the quantification using
ImageQuant 5.2 software (Healthcare Bio-Sciences, Philadelphia,
PA, USA).
STATISTICAL ANALYSIS
The results are presented as mean ± s.e.m. Statistical evaluations
involved One-Way ANOVA followed by Dunnett’s test or Fisher’s
least significant difference procedure for multiple comparisons as
appropriate. Differences were considered statistically significant
at p < 0.05.
FIGURE 1 | Eicosapentaenoic acid (EPA) attenuates cigarette smoke
(CS)-induced lung inflammation in mice. Four groups of mice were
subchronically exposed to air or CS for 4 weeks. Two of the four study
groups received daily treatment with EPA (50mg/kg body weight) or vehicle
(50% alcohol and 50% DMSO) by gastric gavage during the 4-week
exposure. (A,B) Representative images of H&E stained lung sections. The
magnifications of each (A,B) are 100X and 400X, respectively. (C) Lung
inflammatory scores were calculated according to the sum of the levels of
cell infiltration and damage levels as assessed from the lung sections. Data
in each group are mean ± s.e.m. from 6 mice. ∗p < 0.05 vs. the
air-exposure group; #p < 0.05 vs. the CS-exposure group with vehicle
treatment.
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RESULTS
EFFECT OF EPA ON INFLAMMATORY MANIFESTATIONS IN MICE
Exposure of mice to CS for 4 weeks resulted in the develop-
ment of lung inflammation as evidenced by the histological
evaluation of the H&E stained lung sections. The inflammatory
manifestations included extensive infiltration of inflammatory
cells, thickening of the alveolar walls and the presence of abnor-
mal re-epithelialization in the CS-exposure mice (Figures 1A,B);
these changes were found to be less in the CS-exposure mice
that underwent EPA treatment (Figures 1A,B). Comparisons of
the group data in terms of lung inflammatory scores confirmed
this difference in the degree of histopathological manifestations
between the CS-exposure mice with and without EPA treat-
ment (Figure 1C). Additionally, compared to the air-exposure
mice, the CS-exposure mice were found to show increases in
total protein levels (Figure 2A), total cell counts (Figure 2B) and
differential cell counts (Figure 2C) in BALF. All of these inflam-
matory indices were significantly alleviated in the CS-exposure
mice that underwent EPA treatment (Figure 2). These inflamma-
tory manifestations were not found in the air-exposure mice that
underwent EPA treatment (Figures 1, 2).
EFFECT OF EPA ON INCREASES IN CHEMOKINES AND OXIDATIVE
STRESS IN MICE
Compared to the air-exposure mice, exposure of mice to CS for
4 weeks resulted in increases in the levels of MIP-2 (Figure 3A),
MCP-1 (Figure 3B), and KC (Figure 3C) in the lung tissue sam-
ples. The increases in the levels of these chemokines were found
to be significantly reduced in the CS-exposure mice that had
underwent EPA treatment (Figure 3). Additionally, compared to
the air-exposure mice, exposure of mice to CS led to an increase
in MDA levels, a biomarker of oxidative stress, in the lung tissue
samples, which was found to be significantly attenuated in the
CS-exposure mice that underwent EPA treatment (Figure 3D).
EPA treatment did not produce notable changes in levels of these
chemokines and of MDA in the air-exposure mice (Figure 3).
EFFECT OF EPA ON THE INDUCTION OF IL-8 IN HBECs
In addition, we used HBECs as an in vitro model to study the
therapeutic mechanism of EPA. Based upon the concentration
and time-response relationships reported previously (Tang et al.,
2011; Liu et al., 2014; Wu et al., 2014), exposure of HBECs to 3%
CSE for 24 h was employed as the standard challenge to induce
IL-8. Pretreatment with various concentrations of EPA (0, 1, 2,
and 5μM) concentration-dependently attenuated the induction
of IL-8 by CSE, whereas pretreatment with EPA in cells without
CSE stimulation failed to alter the expression of IL-8 (Figure 4).
The results obtained from MTT assay indicated that exposure of
HBECs to EPA at a concentration of 5μM for 24 h did not alter
cell viability (102.4 ± 3.5% of control). Based on the above, we
employed 5μM EPA as the standard treatment.
EFFECT OF EPA ON THE INCREASE IN INTRACELLULAR ROS IN HBECs
Increases in intracellular ROS, via activation of NADHP oxidase,
are an important trigger for the induction of IL-8 by CSE in
HBECs (Tang et al., 2011; Wu et al., 2014). Compared to con-
trol cells, exposure of HBECs to 3% CSE for 30min resulted in
increases in intracellular levels of both superoxide (Figure 5A)
FIGURE 2 | Eicosapentaenoic acid (EPA) attenuates cigarette smoke
(CS)-induced increases in total protein content (A), total cell count (B)
and differential cell count (C) in bronchoalveolar lavage fluid (BALF).
These indices were measured and served as indications of lung
inflammation. Data in each group are mean ± s.e.m. from 6 mice.
∗p < 0.05 vs. the air-exposure group; #p < 0.05 vs. the CS-exposure group
with vehicle treatment. See the legend of Figure 1 for detailed information
on each study group.
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FIGURE 3 | Eicosapentaenoic acid (EPA) attenuates cigarette smoke
(CS)-induced increases in pro-inflammatory chemokines and
malondialdehyde in lung tissues sampled from mice. Levels of
macrophage inflammatory protein 2 (MIP-2) (A), monocyte chemoattractant
protein-1 (MCP-1) (B) and keratinocyte chemoattractant (KC) (C) in lung
tissues were analyzed by ELISA. Levels of malondialdehyde (MDA) (D) were
measured by an assay kit and served as an indication of oxidative stress. Data
in each group are mean ± s.e.m. from 6 mice. ∗p < 0.05 vs. the air-exposure
group; #p < 0.05 vs. the CS-exposure group with vehicle treatment. See the
legend of Figure 1 for detailed information on each study group.
FIGURE 4 | Eicosapentaenoic acid (EPA) dose-dependently attenuates
the induction of IL-8 by cigarette smoke extract (CSE) in human
bronchial epithelial cells. Cells were incubated with medium alone or 3%
CSE for 24 h with pretreatment with vehicle or various concentrations (1, 2,
and 5μM) of EPA. Protein levels of IL-8 in the cell lysates were analyzed by
Western blotting. Data in each group are mean ± s.e.m. from five
independent experiments. ∗p < 0.05 vs. control (vehicle without CSE
stimulation). #p < 0.05 vs. CSE without EPA pretreatment.
and hydrogen peroxide (Figure 5B). The CSE-induced increases
in intracellular ROS were prevented by pretreatment with EPA
(Figure 5). Further analysis revealed that exposure of HBECs to
3% CSE for 15min led to an increase in the activity of NADPH
oxidase and this was found to be suppressed by pretreatment
with EPA (Figure 6). Pretreatment with EPA in cells without
CSE stimulation failed to alter the levels of intracellular ROS
(Figure 5) and the activity of NADPH oxidase (Figure 6).
EFFECT OF EPA ON THE ACTIVATION OF MAPKS/NF-κB SIGNALING
Activation of ERK, JNK, and NF-κB is known to be a ROS-
sensitive signaling pathway that is vital to the induction of IL-8
by CSE in HBECs (Tang et al., 2011; Liu et al., 2014; Wu et al.,
2014). Compared to control cells, exposure of HBECs to 3% CSE
for 6 h resulted in increases in the amount of both phospho-
rylated ERK (Figure 7A) and phosphorylated JNK (Figure 7B).
Furthermore, exposure of HBECs to 3% CSE for 12 h resulted in
an increase in the amount of NF-κB p65 subunit present in the
nuclei of cells (Figure 7C). Such CSE-induced activation of the
MAPKs/NF-κB signaling was significantly attenuated by pretreat-
ment with EPA (Figure 7). Pretreatment with EPA in cells without
CSE stimulation failed to alter the expression of these proteins
(Figure 7).
DISCUSSION
Our in vivo study demonstrates clearly that subchronic CS expo-
sure of mice for 4 weeks causes lung inflammation as evidenced
in lung tissue samples by histopathological manifestations as well
as several inflammatory indices, such as an increase in BALF total
cell count, an increase in BALF differential cell count an increase
in total protein and increased levels of various inflammatory
chemokines, including MIP-2, MCP-1, and KC. All these are
potent chemokines related to the initiation and progression of
lung inflammation induced by CS (Yoshida and Tuder, 2007) and,
among these chemokines, MIP-2 and KC are murine homologs of
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FIGURE 5 | Eicosapentaenoic acid (EPA) attenuates increases in
intracellular levels of reactive oxygen species (ROS) induced by cigarette
smoke extract (CSE) in human bronchial epithelial cells. Cells were
exposed to medium alone or 3% CSE for 30min with pretreatment with EPA
(5μM) or its vehicle. After exposure, the cells were collected for the
measurement of intracellular ROS levels. Levels of ROS were measured by
HE/ETH (A) and DCFH-DA/DCFH (B) fluorescent probes. Data in each group
are mean ± s.e.m. from five independent experiments. ∗p < 0.05 vs. control
(vehicle without CSE stimulation). #p < 0.05 vs. CSE without EPA
pretreatment.
FIGURE 6 | Eicosapentaenoic acid (EPA) attenuates the increase in
NADPH oxidase activity induced by cigarette smoke extract (CSE) in
human bronchial epithelial cells. Cells were exposed to medium alone or
to 3% CSE for 15min with EPA (5μM) or its vehicle. NADPH oxidase
activity was measured by NADP+/NADPH assay. Data in each group are
mean ± s.e.m. from five independent experiments. ∗p < 0.05 vs. control
(vehicle without CSE stimulation). #p < 0.05 vs. CSE without EPA
pretreatment.
IL-8. Subchronic CS exposure also was found to cause an increase
in oxidative stress as reflected by the increased level of MDA in
the lungs. All of these CS-induced events are similar to those
described previously (Barnes, 2004; Thorley and Tetley, 2007;
Tang et al., 2011; Liu et al., 2014; Wu et al., 2014). Importantly, all
of these CS-induced pathophysiological events were found to be
suppressed by daily treatment with EPA, suggesting that EPA has
both anti-inflammatory and antioxidant functions against CS-
induced lung inflammation in vivo. To investigate the therapeutic
mechanism of EPA, we then employed HBECs to study the
induction of IL-8 by CSE; this is because IL-8 produced by lung
epithelial cells is important to the induction of lung inflammation
by CS (Mossman et al., 2006; Thorley and Tetley, 2007; Moretto
et al., 2008; Tang et al., 2011; Liu et al., 2014; Wu et al., 2014).
Our in vitro study demonstrates that exposure of HBECs to CSE
sequentially activated NADPH oxidase, increased intracellular
ROS level, activated both MAPKs and NF-κB, and induced IL-
8. Previous studies have revealed that the CSE-induced increase
in intracellular ROS is mediated through activation of NADHP
oxidase and this is an important trigger for the ROS-sensitive
MAPKs/NF-κB signaling pathway that leads to the induction of
IL-8 in HBECs (Tang et al., 2011; Liu et al., 2014; Wu et al., 2014).
Notably, all of these CSE-induced consequences were suppressed
by pretreatment with EPA, indicating that the beneficial effect of
EPA may be mediated through its antioxidant activity and via the
inhibition of the ROS-sensitive inflammatory signaling.
Our study appears to be the first to report that EPA has
both antioxidant and anti-inflammatory properties against CS-
induced lung inflammation. These two beneficial activities of EPA
have been suggested by previous studies that have focused on
stimuli other than CS insult. Indeed, supplementation of EPA
has been shown to suppress the chronic inflammation in sev-
eral animal models including ovalbumin-induced asthma in mice
(Schuster et al., 2014), high-fat diet-induced metabolic syndrome
in rats (Poudyal et al., 2013), high fat-cholesterol diet-induced
fibrotic steatohepatitis in rats (Jia et al., 2012) and ischemic
brain injury in gerbils (Okabe et al., 2011). Using an in vitro
preparation, administration of EPA has been demonstrated to
attenuate inflammatory responses to stimuli in macrophages
(Mickleborough et al., 2009; Mullen et al., 2010; Wang et al.,
2010; Jinno et al., 2011; Jung et al., 2012), mast cells (van den
Elsen et al., 2013), myoblasts (Magee et al., 2012), and microglia
(Moon et al., 2007). In addition to its anti-inflammatory activ-
ity, administration of EPA has been reported to suppress ROS
generation in vivo (Richard et al., 2008; van den Elsen et al., 2013).
EPA also possesses antioxidant activity in type 2 diabetic patients
(Mahmoudabadi and Rahbar, 2014), in rats exposed to organic
pollutants (Palaniswamy et al., 2014) and against oxidative
stress in adipocytes (Kusunoki et al., 2013). Thus, our findings
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FIGURE 7 | Eicosapentaenoic acid (EPA) attenuates the activation of ERK,
JNK and NF-κB signaling by cigarette smoke extract (CSE) in human
bronchial epithelial cells. Cells were exposed tomedium alone or 3%CSE for
6 (A,B) or 12 h (C)with pretreatment with EPA (5μM) or its vehicle. Protein
expression was analyzed by Western blotting. ∗p < 0.05 vs. control (vehicle
without CSE stimulation). #p < 0.05 vs. CSE without EPA pretreatment.
are in good agreement with the above previously reported
observations.
There are at least three possibilities to explain the sup-
pressive effect of EPA on the CS-induced lung inflammation
in our model system. First, EPA may prevent the CS-induced
increase in intracellular ROS via suppression of the activation of
NADPH oxidase (Morre et al., 2010) as indicated in this study
or via scavenging ROS (Richard et al., 2008). EPA has also been
reported to up-regulate antioxidant enzymes (Kusunoki et al.,
2013; Mahmoudabadi and Rahbar, 2014; Palaniswamy et al.,
2014). While the latter mechanism may be possible explanation
of our in vivo study, it is unlikely to be true for our in vitro
study. This is because the effective treatment time with EPA
(30min) is too short to suppress the increase in intracellular ROS
perhaps via the up-regulation of an antioxidant system. Since the
induction of lung inflammatory mediators by CS is mainly regu-
lated by ROS-sensitive signaling pathways (Mossman et al., 2006;
Rahman and Adcock, 2006; Tang et al., 2011; Wu et al., 2014),
it is plausible that the anti-inflammatory effect of EPA is linked
to its antioxidant function. Secondly, we should also include the
possibility that EPA directly interferes with the activation of this
signaling pathway because this has been suggested by other inves-
tigators (Mullen et al., 2010; Jia et al., 2012; Magee et al., 2012;
van den Elsen et al., 2013). Thirdly, EPA may give rise to lipid
mediators such as E-series resolvins, which are known to have
potent anti-inflammatory and pro-resolution activity (Seki et al.,
2009). In this context, docosahexaenoic acid (DHA), which is
another n-3 PUFA, has been well studied regarding its antioxidant
and anti-inflammatory properties (Chapkin et al., 2009; Giudetti
and Cagnazzo, 2012; Davidson, 2013). While many studies have
shown qualitative and quantitative differences in responses to EPA
andDHA (Russell and Bürgin-Maunder, 2012), certainmetabolic
derivatives of DHA have been shown to have beneficial effects
against CS-induced lung inflammation that are similar to those
reported in this study (Hsiao et al., 2013; Cipollina et al., 2014).
Of note, Shahar et al. reported that the prevalence odds of COPD
in smokers were inversely related to the plasma level of DHA,
but not EPA (Shahar et al., 1999). However, these investigators
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(Shahar et al., 1999) interpreted this discrepancy with caution
because human body can metabolize EPA to DHA and some of
the EPA in the diet may eventually be metabolized to DHA.
Our in vivo studies demonstrate that the EPA-mediated atten-
uation of CS-induced lung inflammation is associated with a
reduction of lung oxidative stress, which is consistent with our
in vitro findings. It is still unknown whether the beneficial effects
of EPA are limited to the induction of chemokines in lung epithe-
lial cells or also apply to other cell types such as leukocytes. If the
latter is true, the target cells for EPA will not be confined to only
the lung epithelial cells because the EPA was given systemically to
the mice in this study. Since we used HBECs for in vitro studies
and mice for in vivo studies, the therapeutic mechanisms of EPA
should be extrapolated carefully to in vivo model. Additionally,
although EPA was administered orally by gavage, no measure-
ments of EPA blood levels and its variability were made. We also
did not attempt to study the dose-dependence in the in vivo effects
of EPA. Of note, our in vitro study shows that the dose of EPA used
did not produce any notable cytotoxicity as revealed by the assay
for cell viability. In our in vivo study, the dose of EPA (50mg/kg)
is within the range of mean daily intakes from food in humans
(EFSA Panel on Dietetic Products, Nutrition and Allergies, 2012)
and was chosen to avoid possible adverse effects. Clinical trials
have reported that a daily consumption of EPA up to 500mg
(Mahmoudabadi and Rahbar, 2014) or 1800mg (Yokoyama et al.,
2007) is safe when treating patients with chronic inflammatory
diseases.
In summary, our findings suggest a novel role for EPA regard-
ing the alleviation of oxidative stress and lung inflammation
induced by subchronic CS exposure in vivo, and the suppression
of the CSE-induced IL-8 in vitro by inhibitingMAPKs/NF-κB sig-
naling, possibly via its antioxidant function. Our findings support
the possibility of using EPA to ameliorate lung inflammation in
smokers.
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